VIRIOS THERAPEUTICS INC (VIRI)

US92829J1043 - Common Stock

0.431  +0.01 (+1.25%)

After market: 0.4398 +0.01 (+2.04%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2023-9-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-6.24M-12.25M-15.96M-10.35M-2.47M
Change In Working Capital
-450.14K200.00K-50.00K-970.00K320.00K
Interest Paid
N/AN/A0.0010.00KN/A
Other non cash items
621.67K580.00K320.00K7.43M70.00K
OPERATING CASH FLOW
-6.07M-11.47M-15.69M-3.90M-2.09M
 
CASH FLOWS FROM INVESTING ACTIVITIES
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A0.001.99M2.43M
Stock Issued/Repurchased
N/A0.00200.00K31.53MN/A
Other Financing Activity
N/A4.49M-300.00K-140.00K-60.00K
FINANCING CASH FLOW
N/A4.49M-100.00K33.38M2.37M
 
CHANGE IN CASH
-5.00M-6.98M-15.79M29.49M280.00K
 
FREE CASH FLOW
Operating Cash Flow
-6.07M-11.47M-15.69M-3.90M-2.09M
FREE CASH FLOW
-6.07M-11.47M-15.69M-3.90M-2.09M

All data in USD

Charts